C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites

Circulation

Volumn 104, Issue 2, 2001, Pages 145-150

  Chambers, John C ^a   Eda, Shinichi ^c   Bassett, Paul ^b   Karim, Yusuf ^a   Thompson, Simon G ^b   Gallimore, J Ruth ^d   Pepys, Mark B ^d   Kooner, Jaspal S ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Inflammation; Population

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

ADULT; ARTICLE; ASIAN; CARDIOVASCULAR RISK; ETHNOLOGY; EUROPE; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035838343     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.2.145     Document Type: Article

References (35)

1. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales
2. Ethnicity and variations in mortality from coronary heart disease
3. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
4. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia
5. The Southall diabetes survey: Prevalence of known diabetes in Asians and Europeans
6. Atherosclerosis: An inflammatory disease
7. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
8. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
9. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
10. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
12. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
13. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
14. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses
15. Risk factors for coronary heart disease and acute-phase proteins: A population-based study
16. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
17. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men
18. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease
19. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
20. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world
21. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-five-year follow-up of the seven countries study
22. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
23. Association between C-reactive protein and features of the metabolic syndrome: A population-based study
24. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
25. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
26. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction
27. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study
28. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE)
29. Emerging epidemic of cardiovascular disease in developing countries
30. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation
31. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
32. C-reactive protein and complement are important mediators of tissue damage in acute myocordial infarction
33. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
34. Tissue-factor antigen and activity in human coronary atherosclerotic plaques
35. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) investigators